Insider · CIK 0001225474

GOLDSTEIN JOSEPH L

Reports to the SEC for 1 company · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001225474

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,962 sh	—	—	1,962
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+155 sh	—	—	6,703
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,958 sh	—	—	1,958
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+166 sh	—	—	6,548
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,707 sh	—	—	0
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,707 sh	$950.00	−$2.57M	6,382
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,707 sh	$625.60	+$1.69M	9,089
2024-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,607 sh	—	—	1,607
2024-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+135 sh	—	—	6,382
2023-02-06	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,613 sh	$482.68	+$1.74M	9,860
2023-02-06	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,613 sh	—	—	0
2023-02-06	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,613 sh	$800.00	−$2.89M	6,247
2023-01-03	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+165 sh	—	—	6,247
2023-01-03	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,929 sh	—	—	1,929
2022-03-30	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,431 sh	$700.00	−$1.7M	6,082
2022-03-30	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,431 sh	$374.12	+$909K	8,513
2022-03-30	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,431 sh	—	—	0
2022-01-03	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+2,707 sh	—	—	2,707
2022-01-03	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+191 sh	—	—	6,082
2021-09-10	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,479 sh	—	—	0
2021-09-10	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,479 sh	$650.00	−$1.61M	5,891
2021-09-10	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,479 sh	$380.95	+$944K	8,370
2021-06-07	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,930 sh	—	—	2,431
2021-06-07	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,930 sh	$374.12	+$722K	7,821
2021-06-07	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,930 sh	$525.00	−$1.01M	5,891
2021-01-04	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+248 sh	—	—	5,891
2021-01-04	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+3,613 sh	—	—	3,613
2020-10-05	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−9,212 sh	$600.00	−$5.53M	5,643
2020-10-05	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,212 sh	—	—	0
2020-10-05	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,212 sh	$520.01	+$4.79M	14,855
2020-09-22	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−20 sh	$552.36	−$11K	5,643
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,600 sh	$549.07	−$1.43M	12,807
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,654 sh	$548.13	−$2M	15,407
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,600 sh	$550.11	−$880K	11,207
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−800 sh	$546.01	−$437K	20,417
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,356 sh	$547.28	−$742K	19,061
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,501 sh	$551.09	−$827K	9,706
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,830 sh	$376.69	+$2.95M	22,217
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−300 sh	$543.19	−$163K	21,917
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,101 sh	$553.17	−$609K	8,092
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,784 sh	$371.40	+$1.41M	9,427
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−700 sh	$544.96	−$381K	21,217
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,960 sh	$380.95	+$1.89M	14,387
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−513 sh	$552.01	−$283K	9,193
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,960 sh	—	—	2,479
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,830 sh	—	—	0
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−899 sh	$554.82	−$499K	7,193
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,530 sh	$555.74	−$850K	5,663
2020-09-21	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,784 sh	—	—	0
2020-08-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,000 sh	$617.18	−$617K	5,643

Recent filings

Accepted (ET)
Jan 64
GOLDSTEIN JOSEPH L0001225474-26-000002
SEC(opens sec.gov)
Jan 64
GOLDSTEIN JOSEPH L0001968202-25-000004
SEC(opens sec.gov)
Jan 254
GOLDSTEIN JOSEPH L0001968202-24-000042
SEC(opens sec.gov)
Jan 44
GOLDSTEIN JOSEPH L0001968202-24-000023
SEC(opens sec.gov)
Feb 84
GOLDSTEIN JOSEPH L0001883850-23-000046
SEC(opens sec.gov)
Jan 54
GOLDSTEIN JOSEPH L0001883850-23-000018
SEC(opens sec.gov)
Apr 14
GOLDSTEIN JOSEPH L0001883850-22-000032
SEC(opens sec.gov)
Jan 54
GOLDSTEIN JOSEPH L0001708138-22-000006
SEC(opens sec.gov)
Sep 134
GOLDSTEIN JOSEPH L0001708138-21-000076
SEC(opens sec.gov)

Companies

REGENERON PHARMACEUTICALS, INC.DirectorREGN

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591